Abacus Global director granted 20,792 shares

Q: What insider activity did Abacus Global Management (ABL) report for Mary Beth Schulte?

Abacus Global Management director Mary Beth Schulte reported receiving a grant of 20,792 shares of Common Stock. This Form 4 filing reflects a compensation-related award, not an open-market stock purchase or sale, and increases her directly held shares.

Q: How many Abacus Global Management shares were granted to Mary Beth Schulte and at what price?

Mary Beth Schulte received a grant of 20,792 Common Stock shares at a reported value of $10.10 per share. This award is coded as a grant, award, or other acquisition (code A) rather than a market transaction in the Form 4.

Q: What are Mary Beth Schulte’s total Abacus Global Management holdings after this Form 4 transaction?

After the reported grant, Mary Beth Schulte directly holds 55,070 shares of Abacus Global Management Common Stock. The Form 4 specifies this as her total shares following the transaction, all categorized as direct ownership rather than indirect holdings.

Q: Does the Mary Beth Schulte Form 4 indicate a stock purchase or a compensation award at Abacus Global Management?

The Form 4 shows a compensation-related award, not an open-market purchase. The transaction uses code A, described as a grant, award, or other acquisition, meaning the shares were granted to the director rather than bought in the market.

Q: What does transaction code A mean in Mary Beth Schulte’s Abacus Global Management Form 4?

Transaction code A in this Form 4 stands for grant, award, or other acquisition. It indicates that Mary Beth Schulte acquired 20,792 shares of Common Stock through an equity award, rather than through buying or selling shares on the open market.

Abacus Global Management, Inc. director Mary Beth Schulte reported a compensation-related stock award rather than an open-market trade.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Abacus Global Management, Inc. director Mary Beth Schulte reported a compensation-related stock award rather than an open-market trade. On March 12, 2026, she acquired 20,792 shares of Common Stock at $10.10 per share. Following this grant, her direct holdings increased to 55,070 shares.

Insider Trade Summary

Grant/Award: 20,792 shares

Grant/Award 1 txn

Insider Schulte Mary Beth

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	20,792	$10.10	$210K

Holdings After Transaction: Common Stock — 55,070 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Abacus Global Management (ABL) report for Mary Beth Schulte?

Abacus Global Management director Mary Beth Schulte reported receiving a grant of 20,792 shares of Common Stock. This Form 4 filing reflects a compensation-related award, not an open-market stock purchase or sale, and increases her directly held shares.

How many Abacus Global Management shares were granted to Mary Beth Schulte and at what price?

Mary Beth Schulte received a grant of 20,792 Common Stock shares at a reported value of $10.10 per share. This award is coded as a grant, award, or other acquisition (code A) rather than a market transaction in the Form 4.

What are Mary Beth Schulte’s total Abacus Global Management holdings after this Form 4 transaction?

After the reported grant, Mary Beth Schulte directly holds 55,070 shares of Abacus Global Management Common Stock. The Form 4 specifies this as her total shares following the transaction, all categorized as direct ownership rather than indirect holdings.

Does the Mary Beth Schulte Form 4 indicate a stock purchase or a compensation award at Abacus Global Management?

The Form 4 shows a compensation-related award, not an open-market purchase. The transaction uses code A, described as a grant, award, or other acquisition, meaning the shares were granted to the director rather than bought in the market.

What does transaction code A mean in Mary Beth Schulte’s Abacus Global Management Form 4?

Transaction code A in this Form 4 stands for grant, award, or other acquisition. It indicates that Mary Beth Schulte acquired 20,792 shares of Common Stock through an equity award, rather than through buying or selling shares on the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/16/2026 - 04:26 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schulte Mary Beth

(Last)

(First)

(Middle)

2101 PARK CENTER DRIVE, SUITE 200

(Street)

ORLANDO

32835

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Abacus Global Management, Inc. [ ABX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/12/2026		A		20,792	A	$10.1	55,070	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

Remarks:

	/s/ Jay Jackson, Power of Attorney for Mary Beth Schulte	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR